Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026)

Nuvalent (NUVL) posted Change in Acquisitions & Divestments of $181.5 million for Q1 2026, up 11.31% on a QoQ basis from $163.1 million in Q4 2025, and down 40.0% year-over-year from $302.6 million in Q1 2025.

Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Nuvalent's Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $181.5 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 40.0% year-over-year to $181.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $812.6 million (up 19.9% YoY) and the FY2025 annual result came in at $933.7 million, up 106.82% from the prior year.
  • Change in Acquisitions & Divestments was $181.5 million for Q1 2026 at Nuvalent, up from $163.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $302.6 million in Q1 2025 and bottomed at $27.0 million in Q1 2022.
  • A 5-year average of $122.6 million and a median of $105.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 296.85% — and 2026, when it sank 40.0%.
  • Nuvalent's Change in Acquisitions & Divestments stood at $97.2 million in 2022, then increased by 13.62% to $110.5 million in 2023, then gained by 28.96% to $142.4 million in 2024, then gained by 14.5% to $163.1 million in 2025, then advanced by 11.31% to $181.5 million in 2026.
  • Business Quant data shows NUVL's Change in Acquisitions & Divestments at $181.5 million in Q1 2026, $163.1 million in Q4 2025, and $232.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Nuvalent 9.75 Bn 9.75 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 181.55 Mn
Mar 31, 2026 181.55 Mn
Dec 31, 2025 163.10 Mn
Dec 31, 2025 163.10 Mn
Sep 30, 2025 232.44 Mn
Sep 30, 2025 232.44 Mn
Jun 30, 2025 235.55 Mn
Jun 30, 2025 235.55 Mn
Mar 31, 2025 302.59 Mn
Mar 31, 2025 302.59 Mn
Dec 31, 2024 142.45 Mn
Dec 31, 2024 142.45 Mn
Sep 30, 2024 127.71 Mn
Sep 30, 2024 127.71 Mn
Jun 30, 2024 105.04 Mn
Jun 30, 2024 105.04 Mn
Mar 31, 2024 76.25 Mn
Mar 31, 2024 76.25 Mn
Dec 31, 2023 110.46 Mn
Dec 31, 2023 110.46 Mn